Investments
34Portfolio Exits
15Funds
2About CRG
CRG, formerly Capital Royalty, is a healthcare-focused investment firm with $1.5 billion of assets under management that provides capital to healthcare companies primarily through structured debt and senior secured loans. CRG works across the spectrum of life science products and technologies and targets investment sizes ranging between $20 million and $200 million. The firm partners with commercial-stage healthcare companies to provide flexible financing solutions so they can achieve their growth objectives. CRG is headquartered in Houston, Texas with offices in Boulder, Colorado and New York City.
CRG Headquarter Location
1000 Main Suite 2500
Houston, Texas, 77002,
United States
713-209-7350
Latest CRG News
May 22, 2014
Submit to Hacker News Here is the latest innovation news from Texas: —Austin, TX-based Filament Labs announced Thursday that it has raised $1 million in seed funding to develop an app that creates digital patient self-care programs with task reminders and educational information and videos. The round was led by Mercury Fund in Houston. —LiveOak Venture Partners closed Tuesday on its inaugural $109 million venture fund aimed at early-stage technology companies. The Austin-based firm began raising money in December and has so far invested in CS Disco , a Houston-based legal IT firm; StepOne , an Austin startup that has developed customer service software; and Veros Systems, which has predictive analytics software. —Capital Royalty in Houston also announced Tuesday that it and New Zealand-based Milford Active Growth Fund have collectively invested $14 million into AFT Pharmaceuticals, which is also based in New Zealand. Capital Royalty will also provide additional capital of up to $30 million in a structured loan facility to the 17-year-old drug company. —Alafair Biosciences last week received a $2 million grant from the Texas Emerging Technology Fund to further the development of the firm’s internal wound-healing devices. Alafair, which is based in Austin, licensed the technology from the University of Texas at Austin. Angela Shah is the editor of Xconomy Texas. She can be reached at ashah@xconomy.com or (214) 793-5763. Follow @angelashah Share or Leave a Comment
CRG Investments
34 Investments
CRG has made 34 investments. Their latest investment was in Treace Medical Concepts as part of their Line of Credit - II on August 8, 2020.
CRG Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/4/2020 | Line of Credit - II | Treace Medical Concepts | $30M | Yes | 4 | |
5/21/2019 | Line of Credit | Aerin Medical | $50M | Yes | 1 | |
3/13/2019 | Debt | Harmony Biosciences | $200M | Yes | 2 | |
11/27/2018 | Unattributed | |||||
10/22/2018 | Series A - III |
Date | 8/4/2020 | 5/21/2019 | 3/13/2019 | 11/27/2018 | 10/22/2018 |
|---|---|---|---|---|---|
Round | Line of Credit - II | Line of Credit | Debt | Unattributed | Series A - III |
Company | Treace Medical Concepts | Aerin Medical | Harmony Biosciences | ||
Amount | $30M | $50M | $200M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 4 | 1 | 2 |
CRG Portfolio Exits
15 Portfolio Exits
CRG has 15 portfolio exits. Their latest portfolio exit was Treace Medical Concepts on April 23, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
4/23/2021 | IPO | 8 | |||
2/3/2021 | Acquired | 9 | |||
12/16/2020 | Acquired | 1 | |||
Date | 4/23/2021 | 2/3/2021 | 12/16/2020 | ||
|---|---|---|---|---|---|
Exit | IPO | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 8 | 9 | 1 |
CRG Fund History
2 Fund Histories
CRG has 2 funds, including CRG Partners IV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
10/11/2019 | CRG Partners IV | $229.85M | 5 | ||
1/4/2017 | CRG Partners III |
Closing Date | 10/11/2019 | 1/4/2017 |
|---|---|---|
Fund | CRG Partners IV | CRG Partners III |
Fund Type | ||
Status | ||
Amount | $229.85M | |
Sources | 5 |
CRG Team
5 Team Members
CRG has 5 team members, including current President, Nathan Hukill.
Name | Work History | Title | Status |
|---|---|---|---|
Nathan Hukill | Highland Capital Management, and Centennial Ventures | President | Current |
Courtney Grobe | Chief Financial Officer, Controller | Current | |
Luke Duster | Chief Investment Officer, Managing Director | Current | |
David Carter | Furman Selz, Chemical Financial Corporation, and Morgan Stanley | Founding Partner | Current |
Scott Li | Hammond Hanlon Camp, PingMD, Lazard Frères & Co., and ABS Ventures | Managing Director | Current |
Name | Nathan Hukill | Courtney Grobe | Luke Duster | David Carter | Scott Li |
|---|---|---|---|---|---|
Work History | Highland Capital Management, and Centennial Ventures | Furman Selz, Chemical Financial Corporation, and Morgan Stanley | Hammond Hanlon Camp, PingMD, Lazard Frères & Co., and ABS Ventures | ||
Title | President | Chief Financial Officer, Controller | Chief Investment Officer, Managing Director | Founding Partner | Managing Director |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.